• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿联酋的乳腺癌生存及其预后因素:一项回顾性研究。

Breast cancer survival and its prognostic factors in the United Arab Emirates: A retrospective study.

机构信息

Department of Medical and Health Sciences, Khawarizmi International College, Abu Dhabi, United Arab Emirates.

Cancer Registry, Tawam Hospital, SEHA, Al Ain, United Arab Emirates.

出版信息

PLoS One. 2021 May 5;16(5):e0251118. doi: 10.1371/journal.pone.0251118. eCollection 2021.

DOI:10.1371/journal.pone.0251118
PMID:33951102
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8099089/
Abstract

BACKGROUND

Data on breast cancer survival and its prognostic factors are lacking in the United Arab Emirates (UAE). Sociodemographic and pathologic factors have been studied widely in western populations but are very limited in this region. This study is the first to report breast cancer survival and investigate prognostic factors associated with its survival in the UAE.

METHODS

This is a retrospective cohort study involving 988 patients who were diagnosed and histologically confirmed with breast cancer between January 2008 and December 2012 at Tawam hospital, Al Ain, UAE. Patient were followed from the date of initial diagnosis until the date of death from any cause, lost-to-follow up or the end of December 2018. The primary outcome is overall survival (OS). The Kaplan-Meier method was used to estimate the survival curve along with the 2- and 5-year survivals. Different group of patients categorized according to prognostic factors were compared using the log-rank test. Multiple Cox proportional hazards models was used to examine the impact of several prognostic factors on the overall survival.

RESULTS

The median study follow-up was 35 months. Of the 988 patients, 62 had died during their follow-up, 56 were lost to follow-up and 870 were still alive at the end of the study. The average age of patients was 48 years. The majority of patients presented to the hospital with grade II or III, 24% with at least stage 3 and 9.2% had metastasis. The 2-year and 5-year survivals were estimated to 97% and 89% respectively. Results of the multiple Cox proportional hazard model show that tumor grade, and stage of cancer at presentation are jointly significantly associated with survival.

CONCLUSION

The 2- and 5-year survival are within the norms compared to other countries. Significant clinical and pathological prognostic factors associated with survival were tumor grade, and the stage of cancer at presentation.

摘要

背景

在阿拉伯联合酋长国(阿联酋),缺乏有关乳腺癌生存及其预后因素的数据。在西方人群中,已经广泛研究了社会人口学和病理学因素,但在该地区非常有限。这项研究首次报告了阿联酋的乳腺癌生存情况,并探讨了与生存相关的预后因素。

方法

这是一项回顾性队列研究,涉及 988 名 2008 年 1 月至 2012 年 12 月期间在阿联酋艾因的 Tawam 医院被诊断和组织学证实患有乳腺癌的患者。患者从初始诊断日期开始随访,直至任何原因死亡、失访或 2018 年 12 月结束。主要结局是总生存(OS)。使用 Kaplan-Meier 方法估计生存曲线以及 2 年和 5 年生存率。根据预后因素对不同组别的患者进行分类,并使用对数秩检验进行比较。使用多 Cox 比例风险模型检查几个预后因素对总体生存的影响。

结果

中位研究随访时间为 35 个月。在 988 名患者中,62 人在随访期间死亡,56 人失访,870 人在研究结束时仍存活。患者的平均年龄为 48 岁。大多数患者因 II 级或 III 级就诊,24%至少为 3 期,9.2%有转移。2 年和 5 年生存率估计分别为 97%和 89%。多 Cox 比例风险模型的结果表明,肿瘤分级和就诊时癌症分期与生存显著相关。

结论

与其他国家相比,2 年和 5 年生存率在正常范围内。与生存相关的显著临床和病理预后因素是肿瘤分级和就诊时癌症分期。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a4c/8099089/6bd036f6f2e4/pone.0251118.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a4c/8099089/0699130d01b4/pone.0251118.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a4c/8099089/6bd036f6f2e4/pone.0251118.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a4c/8099089/0699130d01b4/pone.0251118.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a4c/8099089/6bd036f6f2e4/pone.0251118.g002.jpg

相似文献

1
Breast cancer survival and its prognostic factors in the United Arab Emirates: A retrospective study.阿联酋的乳腺癌生存及其预后因素:一项回顾性研究。
PLoS One. 2021 May 5;16(5):e0251118. doi: 10.1371/journal.pone.0251118. eCollection 2021.
2
Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.初诊时患有乳腺癌骨转移的女性,根据肿瘤亚型的预后因素和生存情况:一项基于 SEER 的研究。
BMC Cancer. 2020 Nov 13;20(1):1102. doi: 10.1186/s12885-020-07593-8.
3
Clinicopathological pattern of colorectal cancer in the United Arab Emirates.阿拉伯联合酋长国结直肠癌的临床病理模式
Saudi Med J. 2003 May;24(5):518-22.
4
The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer.IV 期乳腺癌不同转移部位患者的临床病理特征和生存结局。
BMC Cancer. 2019 Nov 12;19(1):1091. doi: 10.1186/s12885-019-6311-z.
5
Risk and prognostic factors of breast cancer with liver metastases.乳腺癌肝转移的风险和预后因素。
BMC Cancer. 2021 Mar 6;21(1):238. doi: 10.1186/s12885-021-07968-5.
6
Epidemiology of prostate cancer in United Arab Emirates.阿拉伯联合酋长国前列腺癌的流行病学
Med J Malaysia. 2003 Dec;58(5):712-6.
7
EFFECT OF SELECTED PROGNOSTIC AND RISK FACTORS ON SURVIVAL OF WOMEN WITH BREAST CANCER IN GEORGIA.格鲁吉亚选定的预后因素和风险因素对乳腺癌女性患者生存情况的影响
Georgian Med News. 2018 Jun(279):23-28.
8
The combined pN stage and breast cancer subtypes in breast cancer: a better discriminator of outcome can be used to refine the 8th AJCC staging manual.乳腺癌中的联合 pN 分期和乳腺癌亚型:可更好地区分预后的指标,可用于完善第 8 版 AJCC 分期手册。
Breast Cancer. 2018 May;25(3):315-324. doi: 10.1007/s12282-018-0833-0. Epub 2018 Jan 20.
9
Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis.采用创新生存分析方法确定淋巴结阴性乳腺癌患者的预后。
Breast J. 2006 Jan-Feb;12(1):37-47. doi: 10.1111/j.1075-122X.2006.00183.x.
10
Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response.新辅助化疗后病理不完全缓解的乳腺癌预后评估。
BMC Cancer. 2019 Jun 17;19(1):601. doi: 10.1186/s12885-019-5812-0.

引用本文的文献

1
Breast cancer screening and prevention in the UAE: a cross-sectional study of risk awareness and provider engagement.阿联酋的乳腺癌筛查与预防:一项关于风险意识和医疗服务提供者参与度的横断面研究。
BMC Public Health. 2025 Jul 29;25(1):2569. doi: 10.1186/s12889-025-23807-9.
2
Predictors of survival rates among breast cancer patients in Ethiopia: a systematic review and meta-analysis 2024.埃塞俄比亚乳腺癌患者生存率的预测因素:一项2024年的系统评价与荟萃分析
Arch Public Health. 2025 Feb 6;83(1):30. doi: 10.1186/s13690-025-01514-6.
3
BRCA testing and management of BRCA-mutated early-stage breast cancer: a comprehensive statement by expert group from GCC region.

本文引用的文献

1
The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer.肿瘤大小、淋巴结状态和远处转移之间的关系:乳腺癌的起源。
Breast Cancer Res Treat. 2018 Aug;170(3):647-656. doi: 10.1007/s10549-018-4796-9. Epub 2018 Apr 24.
2
Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173,797 patients.现代乳腺癌检测时肿瘤分期对生存的影响:基于173,797例患者的人群研究
BMJ. 2015 Oct 6;351:h4901. doi: 10.1136/bmj.h4901.
3
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).
BRCA检测与BRCA突变早期乳腺癌的管理:海湾合作委员会地区专家组的综合声明
Front Oncol. 2024 Apr 25;14:1358982. doi: 10.3389/fonc.2024.1358982. eCollection 2024.
4
Numb cheek syndrome in breast cancer: a case report.乳腺癌中的面颊麻木综合征:一例报告
Front Oncol. 2024 Mar 11;14:1349073. doi: 10.3389/fonc.2024.1349073. eCollection 2024.
5
Epidemiological, clinical, and pathological characteristics of invasive breast cancer in Bedouin and Jewish women in southern Israel: a retrospective comparative study.以色列南部贝都因和犹太妇女浸润性乳腺癌的流行病学、临床和病理特征:一项回顾性对比研究。
BMC Cancer. 2024 Mar 6;24(1):310. doi: 10.1186/s12885-024-12051-w.
6
Characterizing the Inflammatory Profile of Neutrophil-Rich Triple-Negative Breast Cancer.描绘富含中性粒细胞的三阴性乳腺癌的炎症特征。
Cancers (Basel). 2024 Feb 10;16(4):747. doi: 10.3390/cancers16040747.
7
Breast Cancer in the Arabian Gulf Countries.阿拉伯海湾国家的乳腺癌
Cancers (Basel). 2023 Nov 14;15(22):5398. doi: 10.3390/cancers15225398.
8
Identification of Breast Cancer LCK Proto-Oncogene as a Master Regulator of TNBC Neutrophil Enrichment and Polarization.鉴定乳腺癌 LCK 原癌基因作为三阴性乳腺癌中性粒细胞富集和极化的主要调节因子。
Int J Mol Sci. 2023 Aug 26;24(17):13269. doi: 10.3390/ijms241713269.
9
Breast Cancer in the United Arab Emirates.阿拉伯联合酋长国的乳腺癌
JCO Glob Oncol. 2023 Jan;9:e2200247. doi: 10.1200/GO.22.00247.
10
Breast Cancer in Asia: Incidence, Mortality, Early Detection, Mammography Programs, and Risk-Based Screening Initiatives.亚洲的乳腺癌:发病率、死亡率、早期检测、乳房X光检查项目以及基于风险的筛查举措
Cancers (Basel). 2022 Aug 30;14(17):4218. doi: 10.3390/cancers14174218.
1995 - 2009年全球癌症生存情况监测:对来自67个国家279个基于人群的登记处的25,676,887例患者的个体数据进行分析(CONCORD - 2)
Lancet. 2015 Mar 14;385(9972):977-1010. doi: 10.1016/S0140-6736(14)62038-9. Epub 2014 Nov 26.
4
Breast cancer screening awareness, knowledge, and practice among arab women in the United Arab Emirates: a cross-sectional survey.阿拉伯联合酋长国阿拉伯女性的乳腺癌筛查意识、知识与实践:一项横断面调查
PLoS One. 2014 Sep 29;9(9):e105783. doi: 10.1371/journal.pone.0105783. eCollection 2014.
5
Identifying women at risk for delayed presentation of breast cancer: a cross-sectional study in Estonia.识别乳腺癌延迟就诊风险的女性:爱沙尼亚的一项横断面研究。
BMC Public Health. 2013 Oct 9;13:947. doi: 10.1186/1471-2458-13-947.
6
Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study.2000-2007 年澳大利亚、加拿大、丹麦、挪威、瑞典和英国的乳腺癌生存状况和诊断时分期:一项基于人群的研究。
Br J Cancer. 2013 Mar 19;108(5):1195-208. doi: 10.1038/bjc.2013.6. Epub 2013 Feb 28.
7
Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients.癌症首次症状到治疗的时间间隔:2212 例新诊断癌症患者的队列研究。
BMC Health Serv Res. 2011 Oct 25;11:284. doi: 10.1186/1472-6963-11-284.
8
Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis.1980 年至 2010 年 187 个国家的乳腺癌和宫颈癌:系统分析。
Lancet. 2011 Oct 22;378(9801):1461-84. doi: 10.1016/S0140-6736(11)61351-2. Epub 2011 Sep 14.
9
Age at diagnosis of breast cancer in Arab nations.阿拉伯国家乳腺癌的发病年龄。
Int J Surg. 2010;8(6):448-52. doi: 10.1016/j.ijsu.2010.05.012. Epub 2010 Jun 19.
10
Survival analysis of 1148 women diagnosed with breast cancer in Southern Iran.对伊朗南部1148名被诊断患有乳腺癌的女性进行生存分析。
BMC Cancer. 2009 Jun 5;9:168. doi: 10.1186/1471-2407-9-168.